New Delhi [India], February 15: Human BioSciences, a leader in biotechnology and wound care solutions, is tackling one of our most pressing health challenges: diabetic wounds. With diabetes affecting over 500 million people worldwide, the complications of untreated wounds--such as ulcers and
Researchers have discovered a low-cost anti-inflammatory hydrogel that could one day be used to treat persistent skin lesions such as those observed in diabetics.